Suire Brice R.

Biography

  Mr. Brice R. Suire serves as the Chief Financial Officer of Allecra Therapeutics GmbH. Mr. Suire served as the Chief Financial Officer of MyoPowers Medical Technologies France SAS until January 26, 2017. Mr. Suire served as Financial Adviser at MyoPowers Medical Technologies France SAS (Alternate name, NanoPowers S.A.). Mr. Suire has 25 years of experience in finance. During the last 15 years he worked at Novartis at positions of increasing responsibility. He worked as Global Head of Business Planning Analysis Supply Chain with responsibility over worldwide Novartis Pharmaceuticals Inventories and Warehousing and Distribution costs. Prior to this position he played a significant role in establishing the Novartis Institute for Biomedical Research in Cambridge (USA) where he worked 4 years as Head of Finance for Research Collaborations, getting exposed to strategic alliances with biotech companies and Global Head of Financial Reporting and Accounting for Research (6 sites worldwide including Cambridge). Before moving to the USA, he was Research & Development Business Planning Analyst, Global e-Business Controller and Audit Manager at Novartis in Basel. He started his career with Audit Consultancy companies Mazars in Paris and London and Price Waterhouse Coopers in Madrid. Mr. Suire holds a Master in Finance degree from University of Paris Dauphine and is a Chartered Accountant and IEP obtained at INSEAD.  

Research Interest

 business